MIL:ARBS
Arterra Bioscience · MIL · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 13:29 UTC
Last close
n/aEUR
Market data
10.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
43.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
33.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
4.2%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Where the price sits
lens 6 of 9Its multiple of earnings
10.1x- Where it is now10.1x
- Its sector's middle26.9x
- The market's middle19.9x
Its own year, in the price it trades at
n/aWe hold no closing prices for this company over the last year, so its own range cannot be drawn.
Market data
Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.
Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.
Every figure in this lens
Price against earnings10.1xComputed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Last closen/aMarket data
Not held.
- Source
- market
- Reported in
- EUR